Abstract:Traumatic brain injury (TBI) is one of the most common pathological conditions impacting the central nervous system (CNS). A neurological deficit associated with TBI results from a complex of pathogenetic mechanisms including glutamate excitotoxicity, inflammation, demyelination, programmed cell death, or the development of edema. The critical components contributing to CNS response, damage control, and regeneration after TBI are glial cells–in reaction to tissue damage, their activation, hypertrophy, and proliferation occur, followed by the formation of a glial scar. The glial scar creates a barrier in damaged tissue and helps protect the CNS in the acute phase post-injury. However, this process prevents complete tissue recovery in the late/chronic phase by producing permanent scarring, which significantly impacts brain function. Various glial cell types participate in the scar formation, but this process is mostly attributed to reactive astrocytes and microglia, which play important roles in several brain pathologies. Novel technologies including whole-genome transcriptomic and epigenomic analyses, and unbiased proteomics, show that both astrocytes and microglia represent groups of heterogenic cell subpopulations with different genomic and functional characteristics, that are responsible for their role in neurodegeneration, neuroprotection and regeneration. Depending on the representation of distinct glia subpopulations, the tissue damage as well as the regenerative processes or delayed neurodegeneration after TBI may thus differ in nearby or remote areas or in different brain structures. This review summarizes TBI as a complex process, where the resultant effect is severity-, region- and time-dependent and determined by the model of the CNS injury and the distance of the explored area from the lesion site. Here, we also discuss findings concerning intercellular signaling, long-term impacts of TBI and the possibilities of novel therapeutical approaches. We believe that a comprehensive study with an emphasis on glial cells, involved in tissue post-injury processes, may be helpful for further research of TBI and be the decisive factor when choosing a TBI model.

Astroglial Cells: Emerging Therapeutic Targets in the Management of Traumatic Brain Injury

Microglia: A Potential Drug Target for Traumatic Axonal Injury

Dual Roles of Astrocytes in Plasticity and Reconstruction after Traumatic Brain Injury

The Potential of Stem Cells in Treatment of Traumatic Brain Injury

Molecular Mechanisms and Signaling Pathways of Reactive Astrocytes Responding to Traumatic Brain Injury

Reactive gliosis in traumatic brain injury: a comprehensive review

Progress of Astrocyte Activation and Traumatic Brain Injury Research

Drug Discovery Research for Traumatic Brain Injury Focused on Functional Molecules in Astrocytes

The role of astrocytes in mediating exogenous cell-based restorative therapy for stroke.

AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury

Traumatic Brain Injury: Mechanisms of Glial Response

The Polarization States of Microglia in Tbi: A New Paradigm for Pharmacological Intervention

Astrocytes in intracerebral hemorrhage: impact and therapeutic objectives

Resident immune responses to spinal cord injury: role of astrocytes and microglia

Advanced Therapies for Traumatic Central Nervous System Injury: Delivery Strategy Reinforced Efficient Microglial Manipulation

'Comprehensive review of emerging drug targets in traumatic brain injury (TBI): challenges and future scope

From spreading depolarization to blood-brain barrier dysfunction: navigating traumatic brain injury for novel diagnosis and therapy

Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions

Neuroinflammation and neurodegeneration following traumatic brain injuries

The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury

Glial-Neuronal Interactions in Pathogenesis and Treatment of Spinal Cord Injury